📣 VC round data is live. Check it out!
- Public Comps
- Outset Medical
Outset Medical Valuation Multiples
Discover revenue and EBITDA valuation multiples for Outset Medical and similar public comparables like Sera Prognostics, LENSAR, Spectral AI, Cumberland and more.
Outset Medical Overview
About Outset Medical
Outset Medical Inc is a medical technology company pioneering a technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.
Founded
2003
HQ

Employees
310
Website
Financials (LTM)
EV
$16M
Valuation Multiples
Start free trialOutset Medical Financials
Outset Medical reported last 12-month revenue of $122M and negative EBITDA of ($45M).
In the same LTM period, Outset Medical generated $50M in gross profit, ($45M) in EBITDA losses, and had net loss of ($73M).
Revenue (LTM)
Outset Medical P&L
In the most recent fiscal year, Outset Medical reported revenue of $120M and EBITDA of ($46M).
Outset Medical is unprofitable as of last fiscal year, with gross margin of 39%, EBITDA margin of (39%), and net margin of (68%).
Financial data powered by Morningstar, Inc.
Outset Medical Stock Performance
Outset Medical has current market cap of $71M, and enterprise value of $16M.
Market Cap Evolution
Outset Medical's stock price is $3.81.
Outset Medical share price decreased by 10.8% in the last 30 days, and by 78.3% in the last year.
Outset Medical has an EPS (earnings per share) of $-4.40.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $16M | $71M | -2.1% | -10.8% | 9.2% | -78.3% | $-4.40 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialOutset Medical Valuation Multiples
Outset Medical trades at 0.1x EV/Revenue multiple, and (0.3x) EV/EBITDA.
EV / Revenue (LTM)
Outset Medical Financial Valuation Multiples
As of May 15, 2026, Outset Medical has market cap of $71M and EV of $16M.
Outset Medical has a P/E ratio of (1.0x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Outset Medical Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Outset Medical Margins & Growth Rates
Outset Medical grew revenue by 6% but EBITDA decreased by 8% in the last fiscal year.
In the most recent fiscal year, Outset Medical reported gross margin of 39%, EBITDA margin of (39%), and net margin of (68%).
Outset Medical Margins
Outset Medical Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Outset Medical Operational KPIs
Outset Medical's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.4M for the same period.
Outset Medical's Rule of 40 is (28%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Outset Medical's Rule of X is (19%) (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Outset Medical Competitors
Outset Medical competitors include Sera Prognostics, LENSAR, Spectral AI, Cumberland, Klea, Creo Medical Group, Anatolia Geneworks, FluoGuide, Bactiguard and Xtant Medical.
Most Outset Medical public comparables operate across Medical Devices, Mental Health Technology, HealthTech and DeepTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 311.1x | 123.1x | (0.8x) | (0.7x) | |||
| 1.0x | 1.2x | 301.3x | (92.6x) | |||
| 3.4x | 3.4x | (14.6x) | — | |||
| 1.6x | — | 24.4x | — | |||
| 3.5x | — | 15.4x | — | |||
| 8.4x | 4.7x | (1.5x) | (2.6x) | |||
| 4.6x | — | (34.4x) | — | |||
| — | — | (10.6x) | (9.6x) | |||
This data is available for Pro users. Sign up to see all Outset Medical competitors and their valuation data. Start Free Trial | ||||||
Outset Medical Funding History
Before going public, Outset Medical raised $606M in total equity funding, across 5 rounds.
Outset Medical Funding Rounds
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Outset Medical
| When was Outset Medical founded? | Outset Medical was founded in 2003. |
| Where is Outset Medical headquartered? | Outset Medical is headquartered in United States. |
| How many employees does Outset Medical have? | As of today, Outset Medical has over 310 employees. |
| Who is the CEO of Outset Medical? | Outset Medical's CEO is Leslie L. Trigg. |
| Is Outset Medical publicly listed? | Yes, Outset Medical is a public company listed on Nasdaq. |
| What is the stock symbol of Outset Medical? | Outset Medical trades under OM ticker. |
| When did Outset Medical go public? | Outset Medical went public in 2020. |
| Who are competitors of Outset Medical? | Outset Medical main competitors include Sera Prognostics, LENSAR, Spectral AI, Cumberland, Klea, Creo Medical Group, Anatolia Geneworks, FluoGuide, Bactiguard, Xtant Medical. |
| What is the current market cap of Outset Medical? | Outset Medical's current market cap is $71M. |
| What is the current revenue of Outset Medical? | Outset Medical's last 12 months revenue is $122M. |
| What is the current revenue growth of Outset Medical? | Outset Medical revenue growth (NTM/LTM) is 8%. |
| What is the current EV/Revenue multiple of Outset Medical? | Current revenue multiple of Outset Medical is 0.1x. |
| Is Outset Medical profitable? | No, Outset Medical is not profitable. |
| What is the current EBITDA of Outset Medical? | Outset Medical has negative EBITDA and is not profitable. |
| What is Outset Medical's EBITDA margin? | Outset Medical's last 12 months EBITDA margin is (37%). |
| What is the current EV/EBITDA multiple of Outset Medical? | Current EBITDA multiple of Outset Medical is (0.3x). |
| How many companies Outset Medical has acquired to date? | Outset Medical hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Outset Medical has invested to date? | Outset Medical hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Outset Medical
Lists including Outset Medical
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.